Business Description
iNtRON Biotechnology Inc
NAICS : 325412
SIC : 2836
ISIN : KR7048530000
Compare
Compare
Traded in other countries / regions
048530.Korea IPO Date
2011-01-26Description
iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 125.61 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 24.73 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -37.5 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.77 | |||||
| 9-Day RSI | 31.63 | |||||
| 14-Day RSI | 31.58 | |||||
| 6-1 Month Momentum % | -14.48 | |||||
| 12-1 Month Momentum % | -6.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.27 | |||||
| Quick Ratio | 13.07 | |||||
| Cash Ratio | 12.46 | |||||
| Days Inventory | 89.64 | |||||
| Days Sales Outstanding | 84.28 | |||||
| Days Payable | 12.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.64 | |||||
| Forward Dividend Yield % | 1.64 | |||||
| 5-Year Yield-on-Cost % | 1.66 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 8.46 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.97 | |||||
| Operating Margin % | -32.09 | |||||
| Net Margin % | -90.4 | |||||
| FCF Margin % | -37.4 | |||||
| ROE % | -8.61 | |||||
| ROA % | -7.42 | |||||
| ROIC % | -6.03 | |||||
| ROC (Joel Greenblatt) % | -39.32 | |||||
| ROCE % | -7.47 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.6 | |||||
| PB Ratio | 2.17 | |||||
| Price-to-Tangible-Book | 2.21 | |||||
| Price-to-Operating-Cash-Flow | 33.67 | |||||
| EV-to-EBIT | -19.49 | |||||
| EV-to-EBITDA | -26.54 | |||||
| EV-to-Revenue | 15.45 | |||||
| EV-to-FCF | -41.32 | |||||
| Price-to-Projected-FCF | 1.89 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Price-to-Net-Current-Asset-Value | 3.62 | |||||
| Price-to-Net-Cash | 3.88 | |||||
| Earnings Yield (Greenblatt) % | -5.13 | |||||
| FCF Yield % | -1.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
iNtRON Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 9,422.006 | ||
| EPS (TTM) (â‚©) | -257.559 | ||
| Beta | 1.31 | ||
| Volatility % | 103.54 | ||
| 14-Day RSI | 31.58 | ||
| 14-Day ATR (â‚©) | 227.477319 | ||
| 20-Day SMA (â‚©) | 6432.5 | ||
| 12-1 Month Momentum % | -6.82 | ||
| 52-Week Range (â‚©) | 5250 - 12470 | ||
| Shares Outstanding (Mil) | 33.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
iNtRON Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
iNtRON Biotechnology Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
iNtRON Biotechnology Inc Frequently Asked Questions
What is iNtRON Biotechnology Inc(XKRX:048530)'s stock price today?
The current price of XKRX:048530 is â‚©6100.00. The 52 week high of XKRX:048530 is â‚©12470.00 and 52 week low is â‚©5250.00.
When is next earnings date of iNtRON Biotechnology Inc(XKRX:048530)?
The next earnings date of iNtRON Biotechnology Inc(XKRX:048530) is .
Does iNtRON Biotechnology Inc(XKRX:048530) pay dividends? If so, how much?
The Dividend Yield %  of iNtRON Biotechnology Inc(XKRX:048530) is 1.64% (As of Today), Highest Dividend Payout Ratio of iNtRON Biotechnology Inc(XKRX:048530) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of iNtRON Biotechnology Inc(XKRX:048530) is 1.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers